178 related articles for article (PubMed ID: 12823159)
1. The efficacy of omeprazole twice daily with supplemental H2 blockade at bedtime in the suppression of nocturnal oesophageal and gastric acidity.
Orr WC; Harnish MJ
Aliment Pharmacol Ther; 2003 Jun; 17(12):1553-8. PubMed ID: 12823159
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the effects of immediate-release omeprazole powder for oral suspension and pantoprazole delayed-release tablets on nocturnal acid breakthrough in patients with symptomatic gastro-oesophageal reflux disease.
Castell D; Bagin R; Goldlust B; Major J; Hepburn B
Aliment Pharmacol Ther; 2005 Jun; 21(12):1467-74. PubMed ID: 15948814
[TBL] [Abstract][Full Text] [Related]
3. Bedtime H2 blockers improve nocturnal gastric acid control in GERD patients on proton pump inhibitors.
Xue S; Katz PO; Banerjee P; Tutuian R; Castell DO
Aliment Pharmacol Ther; 2001 Sep; 15(9):1351-6. PubMed ID: 11552905
[TBL] [Abstract][Full Text] [Related]
4. Gastric acidity and acid breakthrough with twice-daily omeprazole or lansoprazole.
Katz PO; Hatlebakk JG; Castell DO
Aliment Pharmacol Ther; 2000 Jun; 14(6):709-14. PubMed ID: 10848653
[TBL] [Abstract][Full Text] [Related]
5. Clinical trial: the effects of adding ranitidine at night to twice daily omeprazole therapy on nocturnal acid breakthrough and acid reflux in patients with systemic sclerosis--a randomized controlled, cross-over trial.
Janiak P; Thumshirn M; Menne D; Fox M; Halim S; Fried M; Brühlmann P; Distler O; Schwizer W
Aliment Pharmacol Ther; 2007 Nov; 26(9):1259-65. PubMed ID: 17944740
[TBL] [Abstract][Full Text] [Related]
6. Gastro-oesophageal reflux associated with nocturnal gastric acid breakthrough on proton pump inhibitors.
Katz PO; Anderson C; Khoury R; Castell DO
Aliment Pharmacol Ther; 1998 Dec; 12(12):1231-4. PubMed ID: 9882031
[TBL] [Abstract][Full Text] [Related]
7. Ranitidine controls nocturnal gastric acid breakthrough on omeprazole: a controlled study in normal subjects.
Peghini PL; Katz PO; Castell DO
Gastroenterology; 1998 Dec; 115(6):1335-9. PubMed ID: 9834259
[TBL] [Abstract][Full Text] [Related]
8. Patterns of 24-hour oesophageal acid exposure after acute withdrawal of acid suppression.
Orr WC; Mellow MH; Grossman MR
Aliment Pharmacol Ther; 1995 Oct; 9(5):571-4. PubMed ID: 8580280
[TBL] [Abstract][Full Text] [Related]
9. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough.
Fackler WK; Ours TM; Vaezi MF; Richter JE
Gastroenterology; 2002 Mar; 122(3):625-32. PubMed ID: 11874994
[TBL] [Abstract][Full Text] [Related]
10. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure.
Ours TM; Fackler WK; Richter JE; Vaezi MF
Am J Gastroenterol; 2003 Mar; 98(3):545-50. PubMed ID: 12650785
[TBL] [Abstract][Full Text] [Related]
11. Morning or evening dosage of omeprazole for gastro-oesophageal reflux disease?
Hendel J; Hendel L; Aggestrup S
Aliment Pharmacol Ther; 1995 Dec; 9(6):693-7. PubMed ID: 8824658
[TBL] [Abstract][Full Text] [Related]
12. Combination drug therapy for gastroesophageal reflux disease.
Cross LB; Justice LN
Ann Pharmacother; 2002 May; 36(5):912-6. PubMed ID: 11978171
[TBL] [Abstract][Full Text] [Related]
13. Control of nocturnal gastric acidity: a role for low dose bedtime ranitidine to supplement daily omeprazole.
Robinson M; Rodriguez-Stanley S; Ciociola AA; Filinto J; Zubaidi S; Miner PB; Gardner JD
Dig Dis Sci; 2002 Feb; 47(2):265-73. PubMed ID: 11855540
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of the clinical implications of acid breakthrough in patients on proton pump inhibitor therapy.
Nzeako UC; Murray JA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1309-16. PubMed ID: 12144581
[TBL] [Abstract][Full Text] [Related]
15. Sleep-related gastro-oesophageal reflux: provocation with a late evening meal and treatment with acid suppression.
Orr WC; Harnish MJ
Aliment Pharmacol Ther; 1998 Oct; 12(10):1033-8. PubMed ID: 9798810
[TBL] [Abstract][Full Text] [Related]
16. Comparison of morning and evening administration of rabeprazole for gastro-oesophageal reflux and nocturnal gastric acid breakthrough in patients with reflux disease: a double-blind, cross-over study.
Pehlivanov ND; Olyaee M; Sarosiek I; McCallum RW
Aliment Pharmacol Ther; 2003 Nov; 18(9):883-90. PubMed ID: 14616152
[TBL] [Abstract][Full Text] [Related]
17. Nocturnal gastric acidity and acid breakthrough on different regimens of omeprazole 40 mg daily.
Hatlebakk JG; Katz PO; Kuo B; Castell DO
Aliment Pharmacol Ther; 1998 Dec; 12(12):1235-40. PubMed ID: 9882032
[TBL] [Abstract][Full Text] [Related]
18. Lansoprazole in the treatment of gastro-oesophageal reflux disease in childhood.
Franco MT; Salvia G; Terrin G; Spadaro R; De Rosa I; Iula VD; Cucchiara S
Dig Liver Dis; 2000 Nov; 32(8):660-6. PubMed ID: 11142573
[TBL] [Abstract][Full Text] [Related]
19. Meal-stimulated gastric acid secretion and integrated gastric acidity in gastro-oesophageal reflux disease.
Gardner JD; Sloan S; Miner PB; Robinson M
Aliment Pharmacol Ther; 2003 Apr; 17(7):945-53. PubMed ID: 12656697
[TBL] [Abstract][Full Text] [Related]
20. Nocturnal acid breakthrough: pH, drugs and bugs.
Tutuian R; Katz PO; Castell DO
Eur J Gastroenterol Hepatol; 2004 May; 16(5):441-3. PubMed ID: 15097034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
